Dr. Jeffrey L. Cummings In The News

Neurology Live
A systematic review of Alzheimer disease (AD) treatments currently in development demonstrate the progressive emphasis on nonamyloid targets, including candidate treatments addressing for inflammation, synapse and neuronal protection, vascular factors, neurogenesis, and epigenetic interventions.
Newswise
Dr. Jeffrey L. Cummings, ÐÔÊӽ紫ý research professor and a leading expert on Alzheimer’s disease clinical trials, led a five-year review of all Alzheimer’s drugs in the development pipeline. He says today there is more hope than ever that we'll one day solve Alzheimer’s.
Philanthropy News Digest
The ÐÔÊӽ紫ý has announced a $6 million commitment from Joy Chambers-Grundy and the late Reg Grundy to establish a center dedicated to research on and the treatment of neurological disorders.
Las Vegas Review Journal
ÐÔÊӽ紫ý announced Monday that it has launched a center dedicated to scientific research about brain and neurological diseases such as Alzheimer’s and dementia.
Newswise
The ÐÔÊӽ紫ý department of brain health has formally launched the Chambers-Grundy Center for Transformative Neuroscience, offering hope through scientific discovery for patients who are suffering from Alzheimer’s, dementia and other brain and neurological diseases.
Yahoo!
An experimental drug could help caregivers as well as patients, as it substantially improved agitation in Alzheimer's patients in a late-stage clinical trial. The announcement boosted the shares of the maker of the treatment, Axsome Therapeutics (AXSM), nearly 25% to more than $95.
Bloomberg
Biogen Inc. stunned Alzheimer’s researchers in March when it said its highly awaited Alzheimer’s treatment aducanumab was unlikely to work. Seven months later, the company reversed course and said the drug did work after all -- at least in one of two large trials.
P.B.S.
Nearly fifty-thousand Nevadans are currently living with Alzheimer's, and that number is only expected to skyrocket over the next decade. On this Nevada Week, we'll explore how close local researchers are to a cure. Plus, what role do citizen scientists and caregivers play toward fighting this neurodegenerative disease?